The Schizophrenia Exome Sequencing Meta-analysis (SCHEMA) consortium is a large multi-site collaboration dedicated to aggregating, generating, and analyzing high-throughput sequencing data of schizophrenia patients to improve our understanding of disease architecture and advance gene discovery.
Scientific field(s): Genetics
The Phase I dataset (GRCh37/hg19) contains the analysis of exomes from 24 248 cases and 97 322 controls, and de novo mutations from 3 402 parent-proband trios.
Method(s): Genome-wide genotyping
The Phase I of SCHEMA actively recruited from diverse global populations, and includes individuals of European, Latin American, East Asian, Ashkenazi Jewish, and African American ancestry. Because the sequence data was generated with various capture technologies over a span of seven years, methods were developed to reduce possible confounders. The first results provided genome-wide significant results associating ultra-rare protein-coding variants in individual genes to risk of schizophrenia. Later releases are planned with larger number of samples that will further increase power, and will be released here before any publication.
Condition(s)/Disease(s): Schizophrenia
Associated ressources:
-
10.1038/s41586-022-04556-w: Singh, T. et al. Rare coding variants in 10 genes confer substantial risk for schizophrenia. Nature 604, 509–516 (2022).
Catalogue record last updated: June 26, 2026, midnight
| Data collectors |
SCHEMA Consortium |
| Data collection period |
2017-now |
| Is data still collected? |
No |
| Variable count/number |
ND |
| Sample size (of participants) |
ND |
| Geographic coverage (of participants) - Countries
|
ND |
| Geographic coverage (of participants) - Regions
|
ND |
| Age range (of participants) |
ND |
| Age range (of participants) - Categories |
ND |
| Family data? |
ND
|
| Database host |
Broad Institute |
| Hosting countries |
United States of America |
| Version (of the database) |
Phase I release |
| File format |
VCF TSV |
| Database size |
ND |
| Data access |
Mixed Access |
| Data sharing policy |
Summary-level data at the variant and gene level are available for viewing and download. All data released on the SCHEMA website are under a Fort Lauderdale Agreement.
For contributing datasets that are permitted to be distributed at the individual level, SCHEMA has deposited the data in a public repository (dbGAP and/or the EGA).
Whole exome sequence data generated under this study are currently hosted on and shared with the collaborating study groups via the controlled access Terra platform (https://app.terra.bio/). Requests for access to the controlled datasets are managed by data custodians of the SCHEMA consortium and the Broad Institute and to sample contributing investigators for approval. |
| Data downloadable? |
Yes |
| Fees |
No |
| Usable for commercial purposes? |
Yes |
| Access for Pasteur scientists |
https://pasteurfr.sharepoint.com/:b:/s/VieScientifique/IQDQ338tr_aQQoQzufjqTGs6Aeb8fmsZTg9Jerj3RW3f2kA?e=fDP7y8
|